Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead-Reference-Cited by-同舟云学术

Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead

Published:2024-09-03 Issue: Volume: Page:
ISSN:1759-5029
Container-title:Nature Reviews Endocrinology
language:en
Short-container-title:Nat Rev Endocrinol

Author:

Grattoni Alessandro^ORCID,Korbutt Gregory,Tomei Alice A.,García Andrés J.^ORCID,Pepper Andrew R.^ORCID,Stabler Cherie,Brehm Michael^ORCID,Papas Klearchos^ORCID,Citro Antonio,Shirwan Haval^ORCID,Millman Jeffrey R.,Melero-Martin Juan^ORCID,Graham Melanie,Sefton Michael,Ma Minglin,Kenyon Norma,Veiseh Omid^ORCID,Desai Tejal A.^ORCID,Nostro M. Cristina^ORCID,Marinac Marjana,Sykes Megan^ORCID,Russ Holger A.,Odorico Jon^ORCID,Tang Qizhi^ORCID,Ricordi Camillo,Latres Esther,Mamrak Nicholas E.,Giraldo Jaime,Poznansky Mark C.^ORCID,de Vos Paul

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41574-024-01029-0.pdf

Reference244 articles.

1. International Diabetes Federation. IDF Diabetes Atlas Reports: Type 1 Diabetes Estimates in Children and Adults (International Diabetes Federation, 2022).

2. US Centers for Disease Control and Prevention. National Diabetes Statistics Report (CDC, 2024).

3. Tonnies, T. et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2060: the SEARCH for diabetes in youth study. Diabetes Care 46, 313–320 (2023).

4. Syed, F. Z. Type 1 diabetes mellitus. Ann. Intern. Med. 175, ITC33–ITC48 (2022).

5. Ebekozien, O. et al. Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the T1D exchange quality improvement collaborative. Diabetes Technol. Ther. 25, 765–773 (2023).